Delivery Order SPE2DB22D3016-SPE2DB25FAHM4

Award Date 12/26/24
Potential Completion Date 12/27/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAHM4
    Delivery Order

This federal contract award with ID SPE2DB22D3016|SPE2DB25FAHM4 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,429.37, is a delivery order for 4,566,798,656 units of the drug Metronidazole 500 mg tablets.

The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, covering similar medical products and prescription drugs.

These contract awards demonstrate AmerisourceBergen's extensive capabilities in distributing a wide array of critical pharmaceutical and medical commodities to various federal government agencies, particularly within the Defense and Justice Departments.

Generated 3/27/25, 9:48 AM